the serum concentrations of ca 50 were measured by an immunoradiometric assay ( ca 50 irma ) in 95 patients with pancreatic cancer and in 94 patients with benign pancreatic , biliary and hepatocellular diseases .
C0235974
pancreatic cancer
C0030274
pancreatic